On February 6, 2020 Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, reported that members from the Replimune management team will participate in fireside chats and host investor meetings at the following two conferences (Press release, Replimune, FEB 6, 2020, View Source [SID1234553918]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim Healthcare Talks Forum – Oncology Day 2020
Date: Thursday, February 13, 2020
Presentation Time: 2:30 pm ET
Location: St. Regis in New York, NY

9th Annual SVB Leerink Global Healthcare Conference
Date: Tuesday, February 25, 2020
Presentation Time: 11:00 am ET
Location: Lotte New York Palace in New York, NY